Chest CT severity and quantitative lung involvement mirror systemic inflammation in hospitalized COVID-19: A lobar-level cohort study
Advances in Medical Sciences · 2026-09 · 71 (2) · 278-288
DOI: 10.1016/j.advms.2026.08.002 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Advances in Medical Sciences, 2026-09. Verfasst von Andrzej Górecki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Diagnostic Center Voxel, Regional Hospital in Łańcut, Łańcut, Poland. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Narodowe Centrum Badań i Rozwoju.
Abstract (Originalsprache)
PURPOSE: COVID-19 has a highly heterogeneous course, requiring objective tools for severity assessment. Chest CT quantifies parenchymal involvement, while laboratory biomarkers reflect systemic inflammatory, immunological, and metabolic responses. This study aimed to assess the associations between quantitative CT-derived measures of lung involvement and laboratory biomarkers in patients hospitalized with COVID-19. MATERIALS AND METHODS: We analyzed a multicenter prospective cohort of 555 adults hospitalized for COVID-19 who underwent baseline low-dose chest CT and laboratory testing within 24 h of admission. Lung involvement was assessed using the CT Severity Score (CTSS; 5-25) and quantitative measures (overall percentage involvement and inflammatory lesion volume). Associations were evaluated using Spearman correlations, and multivariable linear regression was performed for CTSS. RESULTS: CTSS correlated positively with CRP, LDH, ferritin, fibrinogen, and D-dimer, and negatively with lymphocyte percentage and serum albumin. The strongest association was for LDH (ρ = 0.68; p < 0.001). In multivariable analysis, LDH, glucose, creatinine, and lymphocyte percentage remained independently associated with CTSS, explaining ∼40% of its variance. Similar patterns were observed for overall percentage involvement and lesion volume. Lower lobes showed the greatest involvement and the strongest correlations with biomarkers. CONCLUSIONS: CT-derived severity metrics reflect systemic disease burden in hospitalized COVID-19 patients. Integrating quantitative CT measures with laboratory biomarkers may improve risk stratification and support clinical decision-making.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Diagnostic Center Voxel, Regional Hospital in Łańcut, Łańcut, Poland.
- Department of Correct, Clinical and Imaging Anatomy, Medical University of Lublin, Lublin, Poland.
- Department of Orthopedics and Traumatology, Medical University of Lublin, Lublin, Poland; Doctoral School, Medical University of Lublin, Lublin, Poland. Electronic address: bborowski.md@gmail.com.
- Department of Correct, Clinical and Imaging Anatomy, Medical University of Lublin, Lublin, Poland; Department of Orthopedics and Traumatology, Medical University of Lublin, Lublin, Poland.
- Department of Correct, Clinical and Imaging Anatomy, Medical University of Lublin, Lublin, Poland; Department of Radiology, Medical University of Lublin, Lublin, Poland.
Förderung
- Narodowe Centrum Badań i Rozwoju
Zitieren
APA
Górecki, A., Szostak, Z., Bronikowska, A., Kołodziejczyk, K., Jankowska, A., Borowski, B., Piech, P., & Staśkiewicz, G. (2026). Chest CT severity and quantitative lung involvement mirror systemic inflammation in hospitalized COVID-19: A lobar-level cohort study. Advances in Medical Sciences, 71(2), 278-288. https://doi.org/10.1016/j.advms.2026.08.002
Vancouver
Górecki A, Szostak Z, Bronikowska A, Kołodziejczyk K, Jankowska A, Borowski B, et al. Chest CT severity and quantitative lung involvement mirror systemic inflammation in hospitalized COVID-19: A lobar-level cohort study. Advances in Medical Sciences. 2026;71(2):278-288. doi:10.1016/j.advms.2026.08.002
BibTeX
@article{Grecki2026,
author = {Górecki, Andrzej and Szostak, Zuzanna and Bronikowska, Anna and Kołodziejczyk, Karolina and Jankowska, Ada and Borowski, Bartosz and Piech, Piotr and Staśkiewicz, Grzegorz},
title = {Chest CT severity and quantitative lung involvement mirror systemic inflammation in hospitalized COVID-19: A lobar-level cohort study},
journal = {Advances in Medical Sciences},
year = {2026},
volume = {71},
number = {2},
pages = {278--288},
doi = {10.1016/j.advms.2026.08.002}
}
EUVIMED